We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

National Egyptian Network Pediatric Stroke and Hemiplegia Registry

This study is currently recruiting participants.
Verified May 2014 by Sahar M.A. Hassanein, MD, Ain Shams University
Sponsor:
ClinicalTrials.gov Identifier:
NCT02129491
First Posted: May 2, 2014
Last Update Posted: May 2, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Sahar M.A. Hassanein, MD, Ain Shams University
  Purpose
Our aim is to establish multi-center national Egyptian database of information about cerebrovascular stroke and hemiplegia in infants and children from 0 to 18 years of age.

Condition
Stroke With Hemiparesis Perinatal Stroke Focal Neurologic Deficits

Study Type: Observational [Patient Registry]
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Target Follow-Up Duration: 10 Years
Official Title: National Egyptian Network Pediatric Stroke and Hemiplegia Registry

Resource links provided by NLM:


Further study details as provided by Sahar M.A. Hassanein, MD, Ain Shams University:

Primary Outcome Measures:
  • Survival or neurologic deficit after acute cerebrovascular stroke. [ Time Frame: participants will be followed for the duration of hospital stay, an expected average of 6 weeks ]
    Children with acute stroke will be followed till either death or discharge from hospital, all clinical, radiological and therapeutic data will be collected.


Secondary Outcome Measures:
  • Long term neurological deficit [ Time Frame: 12 months ]
    Post-stroke pediatric gross and fine motor function will be assessed.


Estimated Enrollment: 1000
Study Start Date: January 2014
Estimated Study Completion Date: December 2021
Estimated Primary Completion Date: January 2020 (Final data collection date for primary outcome measure)
Groups/Cohorts
Pediatric Stroke and Hemiplegia
Any infant or child with acute stroke or hemiplegia

Detailed Description:

Aims: An open-ended multi-center, national Egyptian study to collect and analyze data for children with cerebrovascular stroke and hemiplegia .

Participants: Eligible infants and children with stroke and hemiplegia.

DESIGN: This study is a prospective cohort study.

Primary outcome measure: Initial acute stroke clinical and radiological presentation, recurrent stroke, mortality, and neurologic deficits in the acute stage, participants will be followed for the duration of hospital stay, an expected average of 6 weeks

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All children from birth to 18 years of age with acute stroke presented by focal neurological signs confirmed by neuroradiology CT or MRI. All children with hemiplegia till the age of 18 years.
Criteria

Inclusion Criteria:

  • Focal neurological deficit of acute onset lasting greater than 20 minutes. And CT or MRI showing infarct in location consistent with neurological signs and symptoms
  • Hemiplegia

Exclusion Criteria:

  1. Cerebral haemorrhage not associated with ischemic infarct.
  2. Hypoxic ischemic event with diffuse or bilateral infarction alone.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02129491


Contacts
Contact: Sahar MA Hassanein, MD, PhD 201223183943 saharhassanein@med.asu.edu.eg

Locations
Egypt
Pediatric Department, Children's Hospital, Faculty of Medicine, Ain Shams University Recruiting
Cairo, Abassia, Egypt, 11381
Contact: Mohsen S Elalfy, MD, PhD       elalfym@hotmail.com   
Principal Investigator: Sahar MA Hassanein, MD, PhD         
Sponsors and Collaborators
Ain Shams University
Investigators
Study Chair: Sahar MA Hassanein, MD, PhD Pediatric Department, Children's Hospital, Faculty of Medicine, Ain Shams University
  More Information

Additional Information:
Responsible Party: Sahar M.A. Hassanein, MD, Professor of Pediatrics, Ain Shams University
ClinicalTrials.gov Identifier: NCT02129491     History of Changes
Other Study ID Numbers: NENPSHR
First Submitted: April 15, 2014
First Posted: May 2, 2014
Last Update Posted: May 2, 2014
Last Verified: May 2014

Keywords provided by Sahar M.A. Hassanein, MD, Ain Shams University:
stroke
Congenital stroke
neonatal
hemiplegia

Additional relevant MeSH terms:
Stroke
Paresis
Hemiplegia
Neurologic Manifestations
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Signs and Symptoms
Paralysis